←
Bill Wierda, MD, PhD29 posts
Bill Wierda, MD, PhD avatar

Bill Wierda, MD, PhD

@wwierda

Professor in the Department of #Leukemia at @MDAndersonNews specializing clinical research of #CLL. Tweets are my own. #endcancer

◷ Joined April 2009▧ 4 Photos and videos
UT MD Anderson avatar
⟳ Bill Wierda, MD, PhD retweeted
UT MD Anderson@UTMDAnderson·13 Apr 2024

“Understanding Richter transformation is one of the biggest unmet needs for patients with chronic lymphocytic leukemia,” says our Dr. William Wierda. Learn more: brnw.ch/21wINbV @wwierda #leukemia #EndCancer

Bill Wierda, MD, PhD avatar
Bill Wierda, MD, PhD@wwierda·22 Sep 2019

Sorry I missed the talk, but did time on IBR correlate with PFS off treatment?

The trial did not report on the dose reductions and relation to outcomes. This data shows that some pts can remain progression free for sometime after stopping ibrutinib. I won’t recommend this strategy outside of a trial.

Bill Wierda, MD, PhD avatar
Bill Wierda, MD, PhD@wwierda·16 Mar 2019

Dr. Philip Thompson speaking this morning at the CLL Patient and Caregiver Educational Forum at MDACC. Great presentation on diagnosing CLL, prognostic factors and first-line treatment.

Post attachment